Independence of measles-specific humoral and cellular immune responses to vaccination

Human Immunology

Volumn 73, Issue 5, 2012, Pages 474-479

  Jacobson, Robert M ^a   Ovsyannikova, Inna G ^a   Vierkant, Robert A ^a   Pankratz, V Shane ^a   Poland, Gregory A ^a  

^a MAYO CLINIC   (United States)

Author keywords

Antibody formation; Cytokines; Immunity, cellular; Immunity, humoral; Measles vaccine

Indexed keywords

ALPHA INTERFERON; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 6; MEASLES VACCINE; NEUTRALIZING ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ANTIBODY BLOOD LEVEL; ARTICLE; CELLULAR IMMUNITY; CORRELATION ANALYSIS; CYTOKINE RELEASE; HUMAN; HUMORAL IMMUNITY; INTERFERON PRODUCTION; MEASLES; MEASLES VACCINATION; MEASLES VIRUS; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL;

ADOLESCENT; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; CELLS, CULTURED; CHILD; COHORT STUDIES; ENZYME-LINKED IMMUNOSPOT ASSAY; FEMALE; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION, SECONDARY; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MALE; MEASLES; MEASLES VACCINE; MEASLES VIRUS; VACCINATION;

EID: 84860259042     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.02.016     Document Type: Article

References (34)

1. Dhiman N., Ovsyannikova I.G., Ryan J.E., Jacobson R.M., Vierkant R.A., Pankratz V.S., et al. Correlations among measles virus-specific antibody, lymphoproliferation and Th1/Th2 cytokine responses following measles-mumps-rubella-II (MMR-II) vaccination. Clin Exp Immunol 2005, 142:498-504.
2. Global measles mortality, 2000-2008. MMWR Morb Mortal Wkly Rep 2009, 58:1321-1326.
3. Immunization surveillance, assessment and monitoring: measles, 2011 2011, World Health Organization, World Health Organization, Geneva, Switzerland.
4. Davey S. Measles eradication still a long way off. Bulletin of the World Health Organization 2001, 584-585. World Health Organization, Geneva, Switzerland.
5. Moss W.J. Measles control and the prospect of eradication. Curr Top Microbiol Immunol 2009, 330:173-189.
6. Griffin D.E., Moss W.J. Can we eradicate measles?. Microbes 2007, 1:409-413.
7. Moss W.J., Strebel P. Biological feasibility of measles eradication. J Infect Dis 2011, 204(suppl 1):s47-s53.
8. Meissner H.C., Strebel P.M., Orenstein W.A. Measles vaccines and the potential for worldwide eradication of measles. Pediatrics 2004, 114:1065-1069.
9. Weekly Epidemiological Record 2011, 173-174. Measles Outbreaks in Europe, World Health Organization, Geneva, Switzerland.
10. Blostein J. Global measles outbreaks threaten US. Mich Med 2008, 104:20-21.
11. Burnet F.M. Measles as an index of immunological function. Lancet 1968, 2:610-613.
12. Kaplan L.J., Daum R.S., Smaron M., McCarthy C.A. Severe measles in immunocompromised patients. JAMA 1992, 267:1237-1241.
13. Markowitz L.E., Chandler F.W., Roldan E.O., Saldana M.J., Roach K.C., Hutchins S.S., et al. Fatal measles pneumonia without rash in a child with AIDS. J Infect Dis 1988, 158:480-483.
14. Mitus A., Holloway A., Enders J.F., Enders J.F. Attenuated measles vaccine in children with acute leukemia. Am J Dis Child 1965, 103:413-418.
15. Ward B.J., Boulianne N., Ratnam S., Guiot M.C., Couillard M., De Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J Infect Dis 1995, 172:1591-1595.
16. Polack F.P., Auwaerter P.G., Lee S.H., Nousari H.C., Valsamakis A., Leiferman K.M., et al. Production of atypical measles in rhesus macaques: Evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody. Nat Med 1999, 5:629-634.
17. Ryan J.E., Ovsyannikova I.G., Poland G.A. Detection of measles virus-specific interferon-gamma-secreting T-cells by ELISPOT. Methods Mol Biol 2005, 302:207-218.
18. Haralambieva I.H., Ovsyannikova I.G., Kennedy R.B., Vierkant R.A., Pankratz V.S., Jacobson R.M., et al. Associations between single nucleotide polymorphisms and haplotypes in cytokine and cytokine receptor genes and immunity to measles vaccination. Vaccine 2011, 29:7883-7895.
19. Ovsyannikova I.G., Haralambieva I.H., Vierkant R.A., Pankratz V.S., Jacobson R.M., Poland G.A. The role of polymorphisms in Toll-like receptors and their associated intracellular signaling genes in measles vaccine immunity. Hum Genet 2011, 130:547-561.
20. Haralambieva I.H., Ovsyannikova I.G., Vierkant R.A., Poland G.A. Development of a novel efficient fluorescence-based plaque reduction microneutralization assay for measles virus immunity. Clin Vaccine Immunol 2008, 15:1054-1059.
21. Ballew H.C. Neutralization. Clinical virology manual 1992, Elsevier, New York. S. Specter (Ed.).
22. Ovsyannikova I.G., Jacobson R.M., Dhiman N., Vierkant R.A., Pankratz V.S., Poland G.A. HLA homozygosity does not adversely affect measles vaccine-induced cytokine responses. Virology 2007, 364:87-94.
23. Ryan J.E., Dhiman N., Ovsyannikova I.G., Vierkant R.A., Pankratz V.S., Poland G.A. Response surface methodology to determine optimal cytokine responses in human peripheral blood mononuclear cells after smallpox vaccination. J Immunol Methods 2009, 341:97-105.
24. Cohen J. Statistical power analysis for the behavioural sciences 1988, Erlbaum, Hillsdale, NJ.
25. Haralambieva I.H., Ovsyannikova I.G., O'Byrne M., Pankratz V.S., Jacobson R.M., Poland G.A. A large observational study to concurrently assess persistence of measles specific B-cell and T-cell immunity in individuals following two doses of MMR vaccine. Vaccine 2011, 29:4485-4491.
26. Yewdell J.W., Norbury C.C., Bennink J.R. Mechanisms of exogenous antigen presentation by MHC class I molecules in vitro and in vivo: implications for generating CD8+ T cell responses to infectious agents, tumors, transplants, and vaccines. Adv Immunol 1999, 73:1-77.
27. Biron C.A. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 1994, 6:530-538.
28. Mosmann T.R. Cytokine secretion patterns and cross-regulation of T cell subsets. Immunol Res 1991, 10:183-188.
29. Mosmann T.R., Coffman R.L. Heterogeneity of cytokine secretion patterns and functions of helper T cells. Adv Immunol 1989, 46:111-147.
30. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989, 7:145-173.
31. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
32. Khan N.U., Pulford K.A., Farquharson M.A., Howatson A., Stewart C., Jackson R., et al. The distribution of immunoreactive interferon-alpha in normal human tissues. Immunology 1989, 66:201-206.
33. Hu X., Ivashkiv L.B. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 2009, 31:539-550.
34. Amanna I.J., Slifka M.K. Contributions of humoral and cellular immunity to vaccine-induced protection in humans. Virology 2011, 411:206-215.